The ROI for life sciences and healthcare community

The LSIT Global Institute is a U.S. 501(c)(3) tax-exempt organization. Contributions are tax deductible as allowed by law.

Life Sciences Industry
For life sciences industries, the shortening of the regulatory approval process for promising new diagnostics and therapeutics - by even a single day represents - a significant and immediately measurable return on investment. The return on investment in the creation of IT mechanisms that result in rapidly obtaining scientifically valid data is immeasurable. GIPs will reduce the time and cost required for regulatory IT validation of the current widely diverse and disparate systems. GIPs will reduce cost and time to develop novel IT systems. And trusted IT systems will enable earlier to revenue and extended patent life of novel diagnostics and therapeutics by dramatically decreasing time to market.

Medical Researchers
The leading academic and research institutions who become Institute members can chose to focus their immense talents on one of the most critical, exciting and interesting tasks of all - the creation of the means to rapidly improve public health. At the same time they can adopt IT systems that add value to industrial partners and make seamless the transference of data and information of licensed out discoveries.

Healthcare Providers
Benefit from state-of-art IT roadmaps that ensure compliance and seamless management of diverse information and data. More effectively collaborate in industrial sponsored clinical research. Ensure specialty data requirements are tightly woven into GIP's. Motivate reduced cost and seamless integration of diagnostics, therapeutics and medical product. And greatly expand medical technological armamentarium for improved patient care.

IT Industry
For information technology companies, the existence of common architectural platforms will enable the creation of highly effective, desirable and competitive products that serve the critical needs of their customers. GIPs will promote much more rapid and expanded adoption of IT. And members will have significant participation in the rapid improvement of global public health, by trusted advancement in IT.

Government Regulatory Bodies
Regulatory agencies will acquire the IT methodology and tools necessary to accomplish their mission of ensuring the safety and efficacy of medical products quickly and effectively and protecting public health. The development of GIP's could reduce and eventually eliminate IT compliance inspections of the current widely diverse and disparate systems.